Table 1.
Anthropometric and biochemical parameters of HIV-positive subjects with lipodystrophy.
| Parameters | Group A | Group B | ||
| Baseline | End of study | Baseline | End of study | |
| BMI (kg/m2) | 26.9 ± 6.1 | 26.8 ± 6.2 | 24.5 ± 3.6 | 24.1 ± 3.6 |
| Mid-arm circumference (cm) | 29.3 ± 5.09 | 29.6 ± 4.7 | 28.7 ± 3.9 | 28.6 ± 3.4 |
| Triceps skinfold (mm) | 13.4 ± 11.4 | 12.7 ± 10.2 | 9.4 ± 4.7 | 10.2 ± 6.1 |
| Waist circumference (cm) | 92.9 ± 13.2 | 92.1 ± 11.2 | 87.5 ± 7.7 | 88.4 ± 7.0 |
| Fat mass (%) | 23.6 ± 11.0 | 24.2 ± 10.3 | 20.0 ± 7.8 | 19.0 ± 8.2 |
| Lean mass (%) | 76.4 ± 11.0 | 75.8 ± 10.3 | 79.9 ± 7.8 | 80.3 ± 9.9** |
| Glucose (mg/dL) | 112.9 ± 50.9 | 109.4 ± 49.2 | 99.5 ± 21.9 | 97.9 ± 15.2 |
| TC (mg/dL) | 239.1 ± 53.6 | 221.4 ± 59.5 | 222.1 ± 66.4 | 209.8 ± 56.0 |
| HDLc (mg/dL) | 38.1 ± 11 | 44.5 ± 16.1 | 37.9 ± 36.6 | 44.9 ± 27.9** |
| LDLc (mg/dL) | 130.6 ± 53.8 | 133.9 ± 56.9 | 141.4 ± 86.4 | 112.1 ± 49.0 |
| TG (mg/dL) | 416.8 ± 267.2 | 303.3 ± 140.6 | 410.4 ± 235.5 | 307.7 ± 150.5** |
Group A: Subjects were monitored two times over a period no longer than six months (n = 18); Group B: Subjects were monitored three times over a period of at least 12 months (n = 35).
**
p<0.05 for differences between time points in Group B only; BMI = body mass index; TC = total cholesterol; TG = triglycerides; HDL = high density lipoprotein; LDL = low density lipoprotein